E. Ohman J:or Asset Management AB
Position in TERN — Terns Pharmaceuticals, Inc.
CIK 2009396
STOCKHOLM, V7
Position in TERN
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$0
+$0 QoQ
Shares Held
22,152
+4.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $53,160,442 across 15 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
304,611 | $25,949,811 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,823 | $4,382,648 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
160,000 | $4,115,200 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
385,000 | $3,780,700 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
85,777 | $3,680,691 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
45,794 | $2,882,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,840 | $2,394,393 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,584 | $1,379,921 |
All Filings in TERN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 22,152 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | — | 21,202 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | — | 102,410 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | — | 102,410 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | — | 102,410 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | — | 80,378 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | — | 61,775 | Shares | Sole | 2024-10-23 | |
| No filing history on record for this holder in this stock. | ||||||